The International Primary Care Respiratory Group (IPCRG) is a global charitable organisation with the goal of improving prevention, diagnosis and care of respiratory diseases in the primary care setting.
touchRESPIRATORY were delighted to catch up with the IPCRG Past-President Prof. Janwillem Kocks (GPRI & University of Groningen, Groningen, Netherlands; OPRI Singapore, Singapore) to learn more around the goals of the IPCRG and their major achievements over the past year.
Questions
- What are the goals of the IPCRG? (1:10)
- What have been the major achievements of the IPCRG in the past year? (1:53)
Disclosures: Janwillem Kocks discloses receiving grant/ research support from AstraZeneca, Boehringer Ingelheim, Chiesi Pharmaceuticals, GSK, TEVA, Valneva; serving on advisory boards for AstraZeneca; receiving honoraria from AstraZeneca, Boehringer Ingelheim, Chiesi Pharmaceuticals, GSK, TEVA, Mundi Pharma, MSD, COVIS Pharma; Janwillem Kocks holds <5% shares of Lothar Medtec GmbH and 72.5% of shares in the General Practitioners Research Institute.
Support:Â Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Victoria Jones.
To find out more visit the IPCRG website here.
